Nanomix Financial Statements From 2010 to 2024

NNMX Stock  USD 0.0002  0.00  0.00%   
Nanomix financial statements provide useful quarterly and yearly information to potential Nanomix investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Nanomix financial statements helps investors assess Nanomix's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Nanomix's valuation are summarized below:
Nanomix does not presently have any fundamental ratios for analysis.
Check Nanomix financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Nanomix's main balance sheet or income statement drivers, such as , as well as many indicators such as . Nanomix financial statements analysis is a perfect complement when working with Nanomix Valuation or Volatility modules.
  
This module can also supplement various Nanomix Technical models . Check out the analysis of Nanomix Correlation against competitors.

Nanomix Company Return On Asset Analysis

Nanomix's Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.

Return On Asset

 = 

Net Income

Total Assets

More About Return On Asset | All Equity Analysis

Current Nanomix Return On Asset

    
  -2.6  
Most of Nanomix's fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Nanomix is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
Competition

Based on the latest financial disclosure, Nanomix has a Return On Asset of -2.5989. This is 70.3% lower than that of the Healthcare sector and 85.64% lower than that of the Medical Devices industry. The return on asset for all United States stocks is notably higher than that of the company.

Nanomix Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Nanomix's current stock value. Our valuation model uses many indicators to compare Nanomix value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Nanomix competition to find correlations between indicators driving Nanomix's intrinsic value. More Info.
Nanomix is considered to be number one stock in return on asset category among its peers. It also is considered to be number one stock in operating margin category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Nanomix by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Nanomix's Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

About Nanomix Financial Statements

Nanomix investors use historical fundamental indicators, such as Nanomix's revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Nanomix. Please read more on our technical analysis and fundamental analysis pages.
Nanomix Corporation develops mobile point-of-care diagnostic system that is used in performing a range of in vitro diagnostic tests in various environments. Nanomix Corporation was founded in 2000 and is headquartered in San Leandro, California. Nanomix Corp operates under Medical Devices classification in the United States and is traded on OTC Exchange. It employs 25 people.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Nanomix Pink Sheet Analysis

When running Nanomix's price analysis, check to measure Nanomix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nanomix is operating at the current time. Most of Nanomix's value examination focuses on studying past and present price action to predict the probability of Nanomix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nanomix's price. Additionally, you may evaluate how the addition of Nanomix to your portfolios can decrease your overall portfolio volatility.